Potential for germ line transmission after intramyocardial gene delivery by adeno-associated virus.
暂无分享,去创建一个
M. Loda | V. Dzau | R. Pratt | Lunan Zhang | L. Melo | A. Pachori
[1] Lili Wang,et al. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[2] Masahiko Hoshijima,et al. Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery , 2002, Nature Medicine.
[3] R. Aikawa,et al. Cardiomyocyte-specific Gene Expression Following Recombinant Adeno-associated Viral Vector Transduction* , 2002, The Journal of Biological Chemistry.
[4] J. Oyama,et al. Gene Therapy Strategy for Long-Term Myocardial Protection Using Adeno-Associated Virus-Mediated Delivery of Heme Oxygenase Gene , 2002, Circulation.
[5] Hiroshi Sato,et al. Rescue of hereditary form of dilated cardiomyopathy by rAAV-mediated somatic gene therapy: Amelioration of morphological findings, sarcolemmal permeability, cardiac performances, and the prognosis of TO-2 hamsters , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[6] J. Biegel,et al. Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.
[7] Y. Kan,et al. Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[8] R. Samulski,et al. Adeno-associated virus vectors for gene therapy: more pros than cons? , 2000, Molecular medicine today.
[9] J. Isner,et al. Left Ventricular Electromechanical Mapping to Assess Efficacy of phVEGF165 Gene Transfer for Therapeutic Angiogenesis in Chronic Myocardial Ischemia , 2000, Circulation.
[10] Kotoku Kurachi,et al. Kinetics of Recombinant Adeno-Associated Virus-Mediated Gene Transfer , 2000, Journal of Virology.
[11] Alan McClelland,et al. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector , 2000, Nature Genetics.
[12] K. Propert,et al. Immune responses to adenovirus and adeno-associated virus in humans , 1999, Gene Therapy.
[13] M. Post,et al. Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. , 1999, Circulation.
[14] M. Kay,et al. Adeno-associated virus vectors and hematology. , 1999, Blood.
[15] E. Svensson,et al. Efficient and stable transduction of cardiomyocytes after intramyocardial injection or intracoronary perfusion with recombinant adeno-associated virus vectors. , 1999, Circulation.
[16] J. Isner,et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. , 1998, Circulation.
[17] R. Samulski,et al. Selective and rapid uptake of adeno-associated virus type 2 in brain. , 1998, Human gene therapy.
[18] D. Russell,et al. Adeno-associated virus vector integration junctions , 1997, Journal of virology.
[19] U. Ikeda,et al. Gene transfer into vascular cells using adeno-associated virus (AAV) vectors. , 1997, Cardiovascular research.
[20] James M. Wilson,et al. Recombinant adeno-associated virus for muscle directed gene therapy , 1997, Nature Medicine.
[21] S. Ponnazhagan,et al. Lack of site-specific integration of the recombinant adeno-associated virus 2 genomes in human cells. , 1997, Human gene therapy.
[22] R. Strumpf,et al. Long-term gene transfer in porcine myocardium after coronary infusion of an adeno-associated virus vector. , 1996, The Annals of thoracic surgery.